iRhythm Technologies (IRTC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for May 27, 2026, to be held virtually, with all stockholders encouraged to vote electronically or by mail.
Key proposals include election of nine directors, approval of a new equity incentive plan, amendment of a subsidiary charter, ratification of a new auditor, and a say-on-pay advisory vote.
Company highlights include 26.2% revenue growth in 2025, first positive GAAP net income quarter, and significant expansion in primary care and international markets.
Ongoing focus on innovation, operational efficiency, and sustainability, with recognition from third-party organizations for corporate responsibility.
Voting matters and shareholder proposals
Election of nine directors for one-year terms.
Approval of the 2026 Equity Incentive Plan, reserving 1,690,000 shares and eliminating the evergreen provision.
Amendment to remove a pass-through voting provision from the subsidiary's certificate of incorporation.
Ratification of KPMG LLP as the new independent registered public accounting firm for 2026, replacing PwC.
Advisory vote on executive compensation (say-on-pay).
Board of directors and corporate governance
Board consists of nine members, 89% independent, with diverse backgrounds and 56% female or ethnically diverse.
Annual board and committee self-evaluations, robust nomination and succession planning, and regular stockholder engagement.
Independent Chairman and all committees composed of independent directors.
Board leadership structure allows flexibility; regular executive sessions held without management.
Latest events from iRhythm Technologies
- AI-driven monitoring, new sensing tech, and global expansion fuel robust growth prospects.IRTC
43rd Annual J.P. Morgan Healthcare Conference 20258 Jul 2026 - Record new account growth, strong LTCM share, and Zio MCT launch drive future expansion.IRTC
Wells Fargo 20th Annual Healthcare Conference 20258 Jul 2026 - Q1 2025 revenue up 20.3%, net loss narrowed, and FY2025 guidance raised amid strong demand.IRTC
Q1 20258 Jul 2026 - Q3 2025 revenue up 31% to $192.9M, margin and EBITDA improved, and guidance raised.IRTC
Q3 20258 Jul 2026 - Q4 revenue up 24% to $164.3M, gross margin at 70%, and 2025 growth guidance reaffirmed.IRTC
Q4 20248 Jul 2026 - Cybersecurity contained, Zio MCT on track for 2027, and AI boosts efficiency and growth.IRTC
Truist Securities MedTech Conference 202617 Jun 2026 - AI innovation, global expansion, and FDA-cleared algorithm drive strong growth and outlook.IRTC
46th Annual William Blair Growth Stock Conference2 Jun 2026 - All five proposals, including director elections and governance changes, were approved.IRTC
AGM 202627 May 2026 - Q1 growth, AI innovation, and expanded patient access drive strong outlook and margin gains.IRTC
Bank of America Global Healthcare Conference 202619 May 2026 - Q1 2026 revenue up 26% to $199.4M, with margin gains and raised full-year guidance.IRTC
Q1 20261 May 2026